Your browser doesn't support javascript.
loading
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients.
Vidal, J; Muinelo, L; Dalmases, A; Jones, F; Edelstein, D; Iglesias, M; Orrillo, M; Abalo, A; Rodríguez, C; Brozos, E; Vidal, Y; Candamio, S; Vázquez, F; Ruiz, J; Guix, M; Visa, L; Sikri, V; Albanell, J; Bellosillo, B; López, R; Montagut, C.
Afiliación
  • Vidal J; Cancer Research Program, FIMIM Hospital del Mar, Barcelona, Spain.
  • Muinelo L; Medical Oncology Department, Hospital del Mar, Barcelona.
  • Dalmases A; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Jones F; Pathology Department, Hospital del Mar, Barcelona.
  • Edelstein D; Sysmex Inostics Inc., Mundelein, USA.
  • Iglesias M; Sysmex Inostics Inc., Mundelein, USA.
  • Orrillo M; Cancer Research Program, FIMIM Hospital del Mar, Barcelona, Spain.
  • Abalo A; Pathology Department, Hospital del Mar, Barcelona.
  • Rodríguez C; Medical Oncology Department, Hospital del Mar, Barcelona.
  • Brozos E; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Vidal Y; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Candamio S; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Vázquez F; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Ruiz J; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Guix M; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Visa L; Traslational Medical Oncology Group (Oncomet)/Liquid Biopsy Analysis Unit, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS) CIBERONC, Santiago de Compostela.
  • Sikri V; Medical Oncology Department, Hospital del Mar, Barcelona.
  • Albanell J; Medical Oncology Department, Hospital del Mar, Barcelona.
  • Bellosillo B; Sysmex Inostics Inc., Mundelein, USA.
  • López R; Cancer Research Program, FIMIM Hospital del Mar, Barcelona, Spain.
  • Montagut C; Medical Oncology Department, Hospital del Mar, Barcelona.
Ann Oncol ; 28(6): 1325-1332, 2017 Jun 01.
Article en En | MEDLINE | ID: mdl-28419195
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ADN de Neoplasias / Análisis Mutacional de ADN / Neoplasias Colorrectales / Genes ras Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: ADN de Neoplasias / Análisis Mutacional de ADN / Neoplasias Colorrectales / Genes ras Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: España